Vote Scores

Home / Companies / Swedish Orphan Biovitrum AB / 14 May 2024

Meeting · year to 30 June 2024100 filers reporting

Swedish Orphan Biovitrum AB: meeting of 14 May 2024

Votes reported on Form N-PX, item by item

100 Form N-PX filers reported votes at the Swedish Orphan Biovitrum AB meeting of 14 May 2024. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

8 nominees; 55.5% of reported votes for; 72 filers withheld from or voted against at least one nominee.

1,145 vote records from 86 filers. 11 of the 73 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

23.3% for14.0% against62.8% other15.1% against management86 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

44 vote records from 22 filers. 1 of the 21 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

86.4% for4.5% against9.1% other4.8% against management22 filers94.8% for3.5% against1.7% other3.5% against management1,497,758 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

308 vote records from 86 filers. 0 of the 73 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

83.7% for0.0% against16.3% other0.0% against management86 filers99.7% for0.0% against0.3% other0.0% against management35,219,138 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

412 vote records from 85 filers. 0 of the 72 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

41.2% for0.0% against58.8% other0.0% against management85 filers88.8% for10.8% against0.4% other10.8% against management40,772,736 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

1,188 vote records from 87 filers. 0 of the 74 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

78.2% for0.0% against21.8% other0.0% against management87 filers92.6% for7.2% against0.2% other7.2% against management144,832,278 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

3,680 vote records from 85 filers. 0 of the 72 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

83.5% for0.0% against16.5% other0.0% against management85 filers99.7% for0.0% against0.3% other0.0% against management422,478,988 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

246 vote records from 10 filers. 0 of the 10 filers that marked the item either way voted against management.

90.0% for0.0% against10.0% other0.0% against management10 filers85.0% for0.0% against15.0% other0.0% against management642,352 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForNo reportFor
BlackRock and iSharesForNo reportFor
FidelitySplit or no voteNo reportSplit or no vote
State Street and SPDRSplit or no voteNo reportFor
American CenturySplit or no voteNo reportFor
Franklin TempletonSplit or no voteNo reportSplit or no vote
InvescoForNo reportFor
EquitableForNo reportFor
Charles SchwabForNo reportFor
Nuveen and TIAASplit or no voteNo reportFor
John Hancock and ManulifeAgainst *ForFor
Morgan Stanley, Eaton Vance and CalvertAgainst *No reportFor
J.P. MorganAgainst *ForFor
Goldman SachsSplit or no voteNo reportSplit or no vote
PGIM and PrudentialAgainst *No reportFor
Jackson National fundsAgainst *ForFor
Northern Trust and FlexSharesForForFor
SEIForNo reportFor
T. Rowe PriceSplit or no voteNo reportFor
ThriventSplit or no voteNo reportFor
Lincoln FinancialSplit or no voteNo reportFor
VoyaForNo reportFor
First TrustSplit or no voteNo reportFor
Russell InvestmentsForNo reportFor
NationwideSplit or no voteNo reportFor
Victory CapitalSplit or no voteNo reportFor
Brighthouse FundsAgainstNo reportFor
BNY MellonSplit or no voteNo reportFor
PrincipalSplit or no voteNo reportFor
TransamericaSplit or no voteNo reportFor
Federated HermesAgainst *No reportFor
AllianceBernsteinSplit or no voteNo reportFor
PIMCOSplit or no voteNo reportFor
Lord AbbettSplit or no voteNo reportFor
Artisan PartnersSplit or no voteNo reportFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Swedish Orphan Biovitrum AB meeting?

100 Form N-PX filers reported votes at the meeting of 14 May 2024. On say-on-pay, 1 of 21 voted against management (4.8%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Swedish Orphan Biovitrum AB on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Swedish Orphan Biovitrum AB

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Swedish Orphan Biovitrum AB with a meeting date within three days of 14 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.